Edwards Lifesciences

Edwards Lifesciences Announces First Human Implants With Mitral Transcatheter Valve System

IRVINE, CA–(Marketwired – March 06, 2014) Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the successful completion of the first three human implants of its FORTIS mitral transcatheter heart valve, which were performed in February and March by the Heart Team at St. Thomas’ […]